Kerneis, S.
et al. "Molecular Studies of the Intestinal Mucosal Barrier Physiopathology using Cocultures of Epithelial and Immune Cells: A Technical Update."
Microbes Infect 2, 9 (2000): 1119-24.
Blijlevens, N. M., J. P. Donnelly, and B. E. De Pauw. "Mucosal Barrier Injury: Biology, Pathology, Clinical Counterparts and Consequences of Intensive Treatment for Haematological Malignancy: An Overview." Bone Marrow Transplant 25, 12 (2000): 1269-78.
Nervi, F. "Significance of Biliary Phospholipids for Maintenance of the Gastrointestinal Mucosal Barrier and Hepatocellular Integrity [editorial]". Gastroenterology 118, 6 (2000): 1265-7.
Ouellette, A. J. "IV Paneth Cell Antimicrobial Peptides and the Biology of the Mucosal Barrier." Am J Physiol 277, 2 Pt 1 (1999): G257-61.
Perdue, M. H. "Mucosal Immunity and Inflammation III. The Mucosal Antigen barrier: Cross Talk with Mucosal Cytokines." Am J Physiol 277, 1 Pt 1 (1999): GI-5.
DeWitt, R. C., and K. A. Kudsk. "The Gut's Role in Metabolism, Mucosal Barrier Function, and Gut Immunology." Infect Dis Clin North Am 13, 2 (1999): 465-81, x.
Diebel, L. N. et al. "Synergistic Effect of Hyperoxia and Unmunoglobulin A on Mucosal Barrier Defense." J Trauma 46, 3 (1999): 374-8; discussion 378-9.
Rescigno, M., M. Urbano, B. Valzasina, M. Francolini, G. Rotta, R. Bonasio, F. Granucci, J. P. Kraehenbuhl, and P. Ricciardi-Castagnoli. "Dendritic Cells Express Tight Junction Proteins and Penetrate Gut Epithelial Monolayers to Sample Bacteria." Nat Immunol 2 (2001): 361-367.
Turner, J. R. " 'Putting the Squeeze' on the Tight Junction: Understanding Cytoskeletal Regulation." Semin Cell Dev Bioi 11, 4 (2000): 301-8.
Mitic, L. L., C. M. Van ltallie, and J. M. Anderson. "Molecular Physiology and Pathophysiology of Tight Junctions I. Tight Junction Structure and Function: Lessons from Mutant Animals and Proteins." Am J Physiol Gastrointest Liver Physiol 279, 2 (2000): G250-4.
Nusrat, A. et al. "The Coiled-Coil Domain of Occludin can Act to Organize Structural and Functional Elements of the Epithelial Tight Junction." J Bioi Chem 275, 38 (2000): 29816-22.
Bazzoni, G. et al. "Interaction of Junctional Adhesion Molecule with the Tight Junction Components ZO-1, Cingulin, and Occludin." J Biol Chem 275, 27 (2000): 20520-6.
Hopkins, A. M. et al. "Modulation of Tight Junction Function by G Protein-Coupled Events." Adv Drug Deliv Rev 41, 3 (2000): 329-40.
Clarke, H. et al. "Modification of Tight Junction Function by Protein Kinase C Isoforms." Adv Drug Deliv Rev 41, 3 (2000): 283-301.
Walsh, S. V., A. M. Hopkins, and A. Nusrat. "Modulation of Tight Junction Structure and Function by Cytokines." Adv Drug Deliv Rev 41, 3 (2000): 303-13.
Lapierre, L. A. "The Molecular Structure of the Tight Junction." Adv Drug Deliv Rev 41, 3 (2000): 255-64.
Tsukita, S., and M. Furuse. "Pores in the Wall: Claudins Constitute Tight Junction Strands Containing Aqueous Pores." J Cell Biol 149, 1 (2000): 13-6.
Fujita, H. et al. "Molecular Deciphennent of Rho Effector Pathways Regulating Tight-Junction Penneability." Biochem J 346, Pt 3 (2000): 617-22.
Kinugasa, T., T. Sakaguchi, X. Gu, and H. C. Reinecker. "Claudins Regulate the Intestinal Barrier in Response to Immune Mediators." Gastroenterology 118 (2000): 1001-1011.
Sabri, S. et al. "Glycocalyx Modulation is a Physiological Means of Regulating Cell Adhesion." J Cell Sci 113, Pt 9 (2000): 1589-600.
Kovbasnjuk, O. N., and K. R. Spring. "The Apical Membrane Glycocalyx of MDCK cells." J Membr Biol 176, 1 (2000): 19-29.
Gebhard, A., and A. Gebert. "Brush Cells of the Mouse Intestine Possess a Specialized Glycocalyx as Revealed by Quantitative Lectin Histochemistry. Further Evidence for a Sensory Function." J Histochem Cytochem 47, 6 (1999): 799-808.
Mantis, N. J., A. Frey, and M. R. Neutra. "Accessibility of Glycolipid and Oligosaccharide Epitopes on Rabbit Villus and Follicle-Associated Epithelium." Am J Physiol Gastrointest Liver Physiol 278, 6 (2000): G915-23.
Sierro, F. et al. "Transient Expression of M-cell Phenotype by Enterocyte-like Cells of the Follicle-Associated Epithelium of Mouse Peyer's Patches. Gastroenterology 119, 3 (2000): 734-43.
Meynell, H. M. et al. "Up-regulation of Microsphere Transport Across the Follicle-associated Epithelium of Peyer's Patch by Exposure to Streptococcus Pneumoniae R36a." FASEB J 13, 6 (1999): 611-9.
Debard, N., F. Sierro, and J. P. Kraehenbuhl. "Development of Peyer's Patches, Follicle-associated Epithelium and M Cell: Lessons from Immunodeficient and Knockout Mice." Semin Immunol 11, 3 (1999): 183-91.
Yamamoto, M. et al. "Alternate Mucosal Immune System: Organized Peyer's Patches are Not Required for IgA Responses in the Gastrointestinal Tract." J Immunol 164, 10 (2000): 5184-91.
Laky, K. et al. "Enterocyte Expression of Interleukin 7 Induces Development of Gammadelta T Cells and Peyer's Patches." J Exp Med 191, 9 (2000): 1569-80.
Iwasaki, A., and B. L. Kelsall. "Localization of Distinct Peyer's Patch Dendritic Cell Subsets and their Recruitment by Chemokines Macrophage Inflammatory Protein (MIP) - 3alpha, MIP-3beta, and Secondary Lymphoid Organ Chemokine." J Exp Med 191, 8 (2000): 1381-94.
Warnock, R. A. et al. "The Role of Chemokines in the Microenvironmental Control of T Versus B Cell Arrest in Peyer's Patch High Endothelial Venules." J Exp Med 191, 1 (2000): 77-88.
Hathaway, L. J., and J. P. Kraehenbuhl. "The Role of M Cells in Mucosal Immunity." Cell Mol Life Sci 57, 2 (2000): 323-32.
Fujimura, Y. "Evidence of M Cells as Portals of Entry for Antigens in the Nasopharyngeal Lymphoid Tissue of Humans." Virchows Arch 436, 6 (2000): 560-6.
Lelouard, H. et al. "Mucin-Related Epitopes Distinguish M Cells and Enterocytes in Rabbit Appendix and Peyer's patches." Infect Immun 67, 1 (1999): 357-67.
Neutra, M. R. "M Cells in Antigen Sampling in Mucosal Tissues." Curr Top Microbiol Immunol 236 (1999): 17-32.
———. "Interactions of Viruses and Microparticles with Apical Plasma Membranes of M Cells: Implications for Human Immunodeficiency Virus Transmission." J Infect Dis 179, Suppl 3 (1999): S441-3.
Owen, R. L. "Uptake and Transport of Intestinal Macromolecules and Microorganisms by M Cells in Peyer's Patches - a Personal and Historical Perspective." Semin Immunol 11, 3 (1999): 157-63.
Sansonetti, P. J., and A. Phalipon. "M Cells as Ports of Entry for Enteroinvasive Pathogens: Mechanisms of Interaction, Consequences for the Disease Process." Semin Immunol 11, 3 (1999): 193-203.
Borghesi, C., M. J. Taussig, and C. Nicoletti. "Rapid Appearance of M Cells After Microbial Challenge is Restricted at the Periphery of the Follicle-associated Epithelium of Peyer's Patch." Lab Invest 79, 11 (1999): 1393-401.
Janin, N. "A Simple Model for Carcinogenesis of Colorectal Cancers with Microsatellite Instability." Adv Cancer Res 77 (2000): 189-221.
Crew, T. E., D. J. Elder, and C. Paraskeva. "A Cyclooxygenase-2 (COX-2) Selective Non-steroidal Anti-inflammatory Drug Enhances the Growth Inhibitory Effect of Butyrate in Colorectal Carcinoma Celli Expressing COX-2 Protein: Regulation of COX-2 by Butyrate." Carcinogenesis 21, 1 (2000): 69-77.
Park, W. S. et al. "A Distinct Tumor Suppressor Gene Locus on Chromosome 15q21.1 in Sporadic Form of Colorectal Cancer." Cancer Res 60, 1 (2000): 70-3.
Chapple, K. S. et al. "Localization of Cyclooxygenase-2 in Human Sporadic Colorectal Adenomas." Am J Pathol 156, 2 (2000): 545-53.
Brabletz, T. et al. "Expression of Nuclear Beta-catenin and C-myc is Correlated with Tumor Size but not with Proliferative Activity of Colorectal Adenomas." Am J Pathol 156, 3 (2000): 865-70.
Roncucci, L. et al. "Aberrant Crypt Foci in Colorectal Carcinogenesis. Cell and Crypt Dynamics." Cell Prolif 33, 1 (2000): 1-18.
O'Brien, H. et al. "K-ras Mutations, Rectal Crypt Cells Proliferation, and Meat Consumption in Patients with Left-sided Colorectal Carcinoma." Eur J Cancer Prev 9, 1 (2000): 41-7.
Wang, M. H., A. L. Kurtz, and Y. Chen. "Identification of a Novel Splicing Product of the RON Receptor Tyrosine Kinase in Human Colorectal Carcinoma Cells." Carcinogenesis 21, 8 (2000): 1507-12.
Tomlinson, I. "Different Pathways of Colorectal Carcinogenesis and their Clinical Pictures." Ann N Y Acad Sci 910 (2000): 10-8; discussion 18-20.
Boland, C. R. "Molecular Genetics of Hereditary Nonpolyposis Colorectal Cancer." Ann NY Acad Sci 910 (2000): 50-9; discussion 59-61.
Giardina, C., H. Boulares, and M. S. Inan. "NSAIDs and Butyrate Sensitize a Human Colorectal Cancer Cell Line to TNF-alpha and Fas Ligation: The Role of Reactive Oxygen Species." Biochim Biophys Acta 1448, 3 (1999): 425-38.
Sakuma, K. et al. "Cyclooxygenase (COX)-2 Immunoreactivity and Relationship to p53 and Ki-67 Expression in Colorectal Cancer." J Gastroenterol 34, 2 (1999): 189-94.
Abdel-Rahman, W. M. et al. "Role of BAX Mutations in Mismatch Repair-deficient Colorectal Carcinogenesis." Oncogene 18, 12 (1999): 2139-42.
Breivik, J., and G. Gaudemack. "Genomic Instability, DNA Methylation, and Natural Selection in Colorectal Carcinogenesis." Semin Cancer Biol 9, 4 (1999): 245-54.
Dyas, M. et al. "Genetic Pathways in Colorectal and Other Cancers." Eur J Cancer 35, 3 (1999): 335-51.
Yan, P. et al. "Telomerase Activation in Colorectal Carcinogenesis." J Pathol 189, 2 (1999): 207-12.
Dannenberg, A. J., and D. Zakim. "Chemoprevention of Colorectal Cancer Through Inhibition of Cyclooxygenase-2." Semin Oncol 26, 5 (1999): 499-504.
Liu, T. et al. "Missense Mutations in hMLH1 Associated with Colorectal Cancer." Hum Genet 105, 5 (1999): 437-41.
Valentini, A. M. et al. "Programmed Cell Death in Colorectal Carcinogenesis." Anticancer Res 19, 4B (1999): 3019-24.
Jiricny, J., and M. "Nystrom-Lahti. Mismatch Repair Defects in Cancer." Curr Opin Genet Dev 10, 2 (2000): 15761.
Karnes, W. E., Jr. "Implications of Low COX-2 Expression in Colorectal Neoplasms with Defective DNA Mismatch Repair." J Cell Biochem 77, S34 (2000): 23-27.
Johannsdottir, J. T. et al. "The Effect of Mismatch Repair Deficiency on Tumourigenesis; Microsatellite Instability Affecting Genes Containing Short Repeated Sequences." Int J Oncol 16, 1 (2000): 133-9.
Lipkin, S. M. et al. "MLH3: A DNA Mismatch Repair Gene Associated with Mammalian Microsatellite Instability." Nat Genet 24, 1 (2000): 27-35.
Lino, H. et al. "DNA Microsatellite Instability and Mismatch Repair Protein Loss in Adenomas Presenting in Hereditary Non-Polyposis Colorectal Cancer." Gut 47, 1 (2000): 37-42.
Morteau, O. et al. "Impaired Mucosal Defense to Acute Colonic Injury in Mice Lacking Cyclooxygenase-l or Cyclooxygenase-2." J Clin Invest 105, 4 (2000): 469-78.
Slomiany, B. L., and A. Slomiany. "Induction of Endothelin-converting Enzyme-1 in Gastric Mucosal Injury by Idomethacin." Biochem Biophys Res Commun 269, 2 (2000): 377-81.
Kelly, D. et al. "Endothelial Changes Precede Mucosal Ulceration Induced by Indomethacin: An Experimental Study in the Rat." Aliment Phannacol Ther 14, 4 (2000): 489-96.
Takahashi, N. et al. "Importance of Gap Junction in Gastric Mucosal Restitution nom Acid-induced Injury." J Lab Clin Med 136, 2 (2000): 93-9.
Vazquez, I. et al. "Protective Effect of Enriched Diet Plus Growth Hormone Administration on Radiation-Induced Intestinal Injury and on its Evolutionary Pattern in the Rat." Dig Dis Sci 44, 11 (1999): 2350-8.
Mylonas, P. G. et al. "Growth Hormone and Insulin-like Growth Factor I Protect Intestinal Cells Nom Radiation Induced Apoptosis." Mol Cell Endocrinol 160, 1-2 (2000): 115-22.
Whittle, B. J. "Pharmacological Approach to the Prevention of Non-steroidal Anti-inflammatory Drug-induced Gastropathy." Ital J Gastroenterol Hepatol 31, (Supplement 1) (1999): S43-7.
Dumenil, G., P. Sansonetti, and G. Tran Van Nhieu. "Src Tyrosine Kinase Activity Down-regulates Rho-dependent Responses during Shigella Entry into Epithelial Cells and Stress Fibre Formation." J Cell Sci 113, (Pt 1) (2000): 71-80.
Wenneras, C. et al. "Blockade of CD14 Increases Shigella-mediated Invasion and Tissue Destruction." J Immunol 164, 6 (2000): 3214-21.
Bourdet-Sicard, R. et al. "Diversion of Cytoskeletal Processes by Shigella During Invasion of Epithelial Cells." Microbes Infect 2, 7 (2000): 813-9.
Philpott, D. J. et al. "Invasive Shigella Flexneri Activates NF-kappa B Through a: Lipopolysaccharide-dependent Innate Intracellular Response and Leads to IL-8 Expression in Epithelial Cells." J Immunol 165, 2 (2000): 903-14.
Mimuro, H. et al. "Profilin is Required for Sustaining Efficient Intra- and Intercellular Spreading of Shigella Flexneri." J Bioi Chem 275, 37 (2000): 28893-901.
Sansonetti, P. I. et al. "Caspase-1 Activation of lL-1beta and IL-18 are Essential for Shigella Flexneri-induced Inflammation." Immunity 12, 5 (2000): 581-90.
Suzuki, T. et al. "Rho Family GTPase Cdc42 is Essential for the Actin-based Motility of Shigella in Mammalian Cells." J Exp Med 191, 11 (2000): 1905-20.
Vimal, D. B. et al. "Intestinal Mucins: The Binding Sites for Salmonella Typhimurium." Mol Cell Biochem 204, 1-2 (2000): 107-17.
Gewirtz, A. T. et al. "Salmonella Typhimurium Induces Epithelial IL-8 Expression via Ca(2+)-mediated Activation of the NF-kappaB Pathway." J Clin Invest 105, 1 (2000): 79-92.
Murray, R. A., and C. A. Lee. "Invasion Genes are not Required for Salmonella Enterica Serovar Typhimurium to Breach the Intestinal Epithelium: Evidence that Salmonella Pathogenicity Island 1 has Alternative Functions During Infection." Infect Immun 68, 9 (2000): 5050-5.
Wallis, T. S., and E. E. Galyov. "Molecular Basis of Salmonella-induced Enteritis." Mol Microbiol 36, 5 (2000): 997-1005.
Zhang, X. L. et al. "Salmonella Enteric a Serovar Typhi Uses Type IVB Pili to Enter Human Intestinal Epithelial Cells." Infect lmmun 68, 6 (2000): 3067-73.
Kingsley, R. A. et al. "The shdA Gene is Restricted to Serotypes of Salmonella Enteric a Subspecies I and Contributes to Efficient and Prolonged Fecal Shedding." lnfect Immun 68, 5 (2000): 2720-7.
Bao, S. et al. "Interferon-gamma Plays a Critical Role in Intestinal Immunity against Salmonella Typhimurium Infection." Immunology 99, 3 (2000): 464-72.
Darwin, K. H., and V. L. Miller. "Molecular Basis of the Interaction of Salmonella with the Intestinal Mucosa." Clin Microbiol Rev 12, 3 (1999): 405-28.
Everest, P. et al. "Evaluation of Salmonella Typhimurium Mutants in a Model of Experimental Gastroenteritis." Infect Immun 67, 6 (1999): 2815-21.
Van den Broeck, W. et al. "The F4 Fnnbrial Antigen of Escherichia Coli and its Receptors." Vet Microbiol 71, 3-4 (2000): 223-44.
Heczko, U., A. Abe, and B. B. Finlay. "In Vivo Interactions of Rabbit Enteropathogenic Escherichia Coli 0103 With its Host: An Electron Microscopic and Histopathologic Study." Microbes Infect 2, 1 (2000): 5-16.
La Ragione, R. M., W. A. Cooley, and M. J. Woodward. "The Role of Fimbriae and Flagella in the Adherence of Avian Strains of Escherichia Coli O78:K80 to Tissue Culture Cells and Tracheal and Gut Explants." J Med Microbiol 49, 4 (2000): 327-38.
Martindale, J. et al. "Genetic Analysis of Escherichia Coli K1 Gastrointestinal Colonization." Mol Microbiol 37, 6 (2000): 1293-1305.
Phillips, A. D., et al. "Enterohaemorrhagic Escherichia Coli O157:H7 Target Peyer's Patches in Humans and Cause Attaching/Effacing Lesions in Both Human and Bovine Intestine." Gut 47, 3 (2000): 377-81.
Sun, R. et al. "Inhibition of Adhesion of Escherichia Coli k88ac Fimbria to its Receptor, Intestinal Mucin-type Glycoproteins, by a Monoclonal Antibody Directed Against a Variable Domain of the Fimbria." Infect Immun 68, 6 (2000): 3509-15.
Jones, N. L. et al. "Escherichia Coli Shiga Toxins Induce Apoptosis in Epithelial Cells that is Regulated by the Bcl-2 Family." Am J Physiol Gastrointest Liver Physiol 278, 5 (2000): G811-9.
Baniett Foster, D. et al. "Enterohemorrhagic Escherichia Coli Induces Apoptosis which Augments Bacterial Binding and Phosphatidylethanolamine Exposure on the Plasma Membrane Outer Leaflet." Infect Immun 68, 6 (2000): 3108-15.
Al-Majali, A. M. et al. "Characterization of the Interaction of Escherichia Coli Heat-stable Enterotoxin (STa) with its Putative Receptor on the Intestinal Tract of Newborn Calves." FEMS Immunol Med Microbiol 28, 2 (2000): 97-104.
de Bernard, M. et al. "The VacA Toxin of Helicobacter Pylori Identifies a New Intermediate Filament-interacting Protein." Embo J 19, 1 (2000): 48-56.
Wessler, S. et al. "Helicobacter Pylori Activates the Histidine Decarboxylase Promoter Through a Mitogenactivated Protein Kinase Pathway Independent of Pathogenicity Island-encoded Virulence Factors." J Bioi Chem 275, 5 (2000): 3629-36.
Rasko, D. A. et al. "Cloning and Characterization of the Alpha (1,3/4) Fucosyltransferase of Helicobacter Pylori." J Bioi Chem 275, 7 (2000): 4988-94.
Donahue, J. P. et al. "Analysis of iceA 1 Transcription in Helicobacter Pylori." Helicobacter 5, 1 (2000): 1-12.
Bereswill, S., et al. "Identification and Molecular Analysis of Superoxide Dismutase Isoforms in Helicobacter Pylori." FEMS Microbiol Lett 183, 2 (2000): 241-5.
Asahi, M. et al. "Helicobacter Pylori CagA Protein can be Tyrosine Phosphorylated in Gastric Epithelial Cells [see comments]." J Exp Med 191, 4 (2000): 593-602.
Logan, S. M., et al. "Functional Genomics of Helicobacter Pylori: Identification of a Beta-1, 4 Galactosyltransferase and Generation of Mutants with Altered Lipopolysaccharide." Mol Microbiol 35, 5 (2000): 1156-67.
Morl, N. et al. "Activation of Intercellular Adhesion Molecule 1 Expression by Helicobacter Pylori is Regulated by NF-kappaB in Gastric Epithelial Cancer Cells." Infect Immun 68, 4 (2000): 1806-14.
Beier, D., and R. Frank. "Molecular Characterization of Two-component Systems of Helicobacter Pylori." J Bacteriol 182, 8 (2000): 2068-76.
Faller, G., and T. Kirchner. "Role of Anti Gastric Autoantibodies in Chronic Helicobacter Pylori Infection." Microsc Res Tech 48, 6 (2000): 321-6.
Morgner, A. et al. "Gastric MALT Lymphoma and its Relationship to Helicobacter Pylori Infection: Management and Pathogenesis of the Disease." Microsc Res Tech 48, 6 (2000): 349-56.
Mittl, P. R. et al. "The Cysteine-rich Protein A from Helicobacter Pylori is a Beta-lactamase." J Bioi Chem 275, 23 (2000): 17693-9.
O'Rourke, E. J. et al. "A Novel 3-methyladenine DNA Glycosylase from Helicobacter Pylori Defines a New Class within the Endonuclease ill Family of Base Excision Repair Glycosylases." J Bioi Chem 275, 26 (2000): 20077-83.
Kuniyasu, H. et al. "Helicobacter Pylori Infection and Carcinogenesis of the Stomach." Langenbecks Arch Surg 385, 2 (2000): 69-74.
Byrd, J. C. et al. "Inhibition of Gastric Mucin Synthesis by Helicobacter Pylori." Gastroenterology 118, 6 (2000): 1072-9.
Beil, W. et al. "Role of VacA and CagA in Helicobacter Pylori Inhibition of Mucin Synthesis in Gastric Mucous Cells." J Clin Microbiol 38, 6 (2000): 2215-8.
Alm, R. A. et al. "Comparative Genomics of Helicobacter Pylori: Analysis of the Outer Membrane Protein Families." Infect Immun 68, 7 (2000): 4155-68.
Maeda, S. et al. "H. Pylori Activates NF-kappaB through a Signaling Pathway Involving LkappaB Kinases, NFkappaB-inducing Kinase, TRAF2, and TRAF6 in Gastric Cancer Cells." Gastroenterology 119, 1 (2000): 97108.
Endo, T. et al. "Cloning and Expression of Beta-1, 4-galactosyltransferase Gene from Helicobacter Pylori." Glycobiology 10, 8 (2000): 809-13.
Ebert, M. P. et al. "Molecular Alterations in Gastric Cancer: The Role of Helicobacter Pylori." Eur J Gastroenterol HepatoZ 12, 7 (2000): 795-8.
Monstein, H. J. et al. "Profiling of Bacterial Flora in Gastric Biopsies from Patients with Helicobacter Pylori-associated Gastritis and Histologically Normal Control Individuals by Temperature Gradient Gel Electropboresis and 16S rDNA Sequence Analysis." J Med Microbiol 49, 9 (2000): 817-22.
O'Toole, P. W., M. C. Lane, and S. Porwollik. "Helicobacter Pylori Motility." Microbes Infect 2, 10 (2000): 1207-14.
Enroth, H. et al. "Helicobacter Pylori Strain Types and Risk of Gastric Cancer: A Case-control Study." Cancer Epidemiol Biomarkers Prev 9, 9 (2000): 981-5.
Solaas, K. et al. "Subcellular Organization of Bile Acid Amidation in Human Liver: A Key Issue in Regulating the Biosynthesis of Bile Salts." J Lipid Res 41, 7 (2000): 1154-62.
Sodeman, T. et al. "Bile Salts Mediate Hepatocyte Apoptosis by Increasing Cell Surface Trafficking of Fas." Am J Physiol Gastrointest Liver Physiol 278, 6 (2000): G992-9.
Hirohashi, T. et al. "A TP-dependent Transport of Bile SaIts by Rat Multidrug Resistance-associated Protein 3 (Mrp3)." J Bioi Chem 275, 4 (2000): 2905-10.
Narain, P. K., E. J. DeMaria, and D. M. Heuman. "Cholesterol Enhances Membrane-damaging Properties of Model Bile by Increasing the Intervesicular-intermixed Micellar Concentration of Hydropbobic Bile Salts." J Surg Res 84, 1 (1999): 112-9.
Nishioka, T. et al. "Partial Replacement of Bile Salts Causes Marked Changes of Cholesterol Crystallization in Supersaturated Model Bile Systems." Biochem J 340 (Pt 2) (1999): 445-51.
Stiehl, A., C. Benz, and P. Sauer. "Mechanism of Hepatoprotective Action of Bile Salts in Liver Disease." Gastroenterol Clin North Am 28, 1 (1999): 195-209, viii.
Nakajima, T. et al. "Bile Acids Increase Intracellular Ca(2+) Concentration and Nitric Oxide Production in Vascular Endothelial Cells." Br J Pharmacol 130, 7 (2000): 1457-67.
Agellon, L. B., and E. C. Torchia. "Intracellular Transport of Bile Acids." Biochim Biophys Acta 1486, 1 (2000): 198-209.
Reyes, H., and J. Sjovall. "Bile Acids and Progesterone Metabolites in Intrahepatic Cholestasis of Pregnancy." Ann Med 32, 2 (2000): 94-106.
Walters, J. R. "Bile Acids are Physiological Ligands for a Nuclear Receptor." Gut 46, 3 (2000): 308-9.
Ung, K. A. et al. "Role of Bile Acids and Bile Acid Binding Agents in Patients with Collagenous Colitis." Gut 46, 2 (2000): 170-5.
Orso, E. et al. "Transport of Lipids from Golgi to Plasma Membrane is Defective in Tangier Disease Patients and Abc1-deficient Mice." Nat Genet 24, 2 (2000): 192-6.
Roy, S. et al. "Dominant-negative Caveolin Inhibits H-Ras Function by Disrupting Cholesterol-rich Plasma Membrane Domains [see comments]." Not Cell Biol 1, 2 (1999): 98-105.
Roper, K., D. Corbeil, and W. B. Huttner. "Retention of Prominin in Microvilli Reveals Distinct Cholesterol Based Lipid Micro-domains in the Apical Plasma Membrane." Nat Cell Bioi 2, 9 (2000): 582-592.
Zager, R. A. "Plasma Membrane Cholesterol: A Critical Determinant of Cellular Energetics and Tubular Resistance to Attack." Kidney Int 58, 1 (2000): 193-205.
Pralle, A. et al. "Sphingolipid-cholesterol Rafts Diffuse as Small Entities in the Plasma Membrane of Mammalian Cells." J Cell Biol 148, 5 (2000): 997-1008.
Verkade, P. et al. "Induction of Caveolae in the Apical Plasma Membrane of Madin-Darby Canine Kidney Cells." J Cell Bioi 148, 4 (2000): 727-39.
Moffett, S., D. A. Brown, and M. E. Linder. "Lipid-dependent Targeting of G Proteins into Rafts." J Bioi Chem 275, 3 (2000): 2191-8.
Heino, S. et al. "Dissecting the Role of the Golgi Complex and Lipid Rafts in Biosynthetic Transport of Cholesterol to the Cell Surface." Proc Natl A cad Sci USA 97, 15 (2000): 8375-80.
Wang, T. Y., R. Leventis, and J. R. Silvius. "Fluorescence-based Evaluation of the Partitioning of Lipids and Lipidated Peptides into Liquid-ordered Lipid Microdomains: A Model for Molecular Partitioning into 'lipid rafts'." Biophys J 79, 2 (2000): 919-33.
Arduino, C., and E. Gaia. "Genetics of Chronic Pancreatitis." Biomed Pharmacother 54, 7 (2000): 394-9.
Chen, J. M., and C. Ferec. "Molecular Basis of Hereditary Pancreatitis." Eur J Hum Genet 8, 7 (2000): 473-9.
Whitcomb, D. C. "Genetic Predispositions to Acute and Chronic Pancreatitis." Med Clin North Am 84, 3 (2000): 531-47, vii.
Kleeff, J. et al. "Chronic Pancreatitis: Pathogenesis and Molecular Aspects." Ann ltal Chir 71, 1 (2000): 3-10.
Teich, N., A. Hoffmeister, and V. Keirn. "Nomenclature of Trypsinogen Mutations in Hereditary Pancreatitis." Hum Mutat 15, 2 (2000): 197-8.
Smithies, A. M. et al. "Investigation of the Interleukin 1 Gene Cluster and its Association with Acute Pancreatitis." Pancreas 20, 3 (2000): 234-40.
O'Reilly, D. A. et al. "Association of Tumour Necrosis Factor Microsatellite Haplotypes with Chronic Pancreatitis." Br J Surg 87, 3 (2000): 362-73.
Mickle, J. E., and G. R Cutting. "Genotype-phenotype Relationships in Cystic Fibrosis." Med C/in North Am 84, 3 (2000): 597-607.
Linsdell, P., A. Evagelidis, and J. W. Hanrahan. "Molecular Determinants of Anion Selectivity in the Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Pore." Biophys J 78, 6 (2000): 2973-82.
Zielenski, J. "Genotype and Phenotype in Cystic Fibrosis." Respiration 67, 2 (2000): 117-33.
Mickle, J. E. et al. "Effects of Cystic Fibrosis and Congenital Bilateral Absence of the Vas Deferens-associated Mutations on Cystic Fibrosis Transmembrane Conductance Regulator-mediated Regulation of Separate Channels." Am J Hum Genet 66, 5 (2000): 1485-95.
Chen, E. Y., M. C. Bartlett, and D. M. Clarke. "Cystic Fibrosis Transmembrane Conductance Regulator has an Altered Structure when its Maturation is Inhibited." Biochemistry 39, 13 (2000): 3797-803.
Skach, W. R. "Defects in Processing and Trafficking of the Cystic Fibrosis Transmembrane Conductance Regulator." Kidney Int 57, 3 (2000): 825-31.
Lu, N. T. and P. L. Pedersen. "Cystic Fibrosis Transmembrane Conductance Regulator: The Purified NBF1+R Protein Interacts with the Purified NBF2 Domain to Form a Stable NBF1 +R/NBF2 Complex While Inducing a Conformational Change Transmitted to the C-terminal Region [published erratum appears in Arch Biochem Biophys 2000 May 1; 377(1): 213]." Arch Biochem Biophys 375, 1 (2000): 7-20.
Weixel, K. M., and N. A. Bradbury. "The Carboxyl Terminus of the Cystic Fibrosis Transmembrane Conductance Regulator Binds to AP-2 Clathrin Adaptors." J Bioi Chem 275, 5 (2000): 3655-60.
Hershkovits, B. S., J. Dagan, and S. Freier. "Increased Spontaneous Chromosomal Breakage in Shwachman Syndrome." J Pediatr Gastroenterol Nutr 28, 4 (1999): 449-50.
Goobie, S. et al. "Exclusion of Linkage of Shwachman-Diamond Syndrome to Chromosome Regions 6q and 12q Implicated by a De Novo Translocation." Am J Med Genet 85, 2 (1999): 171-4.
Ikegawa, S. et al. "Cloning of Translocation Breakpoints Associated with Shwachman Syndrome and Identification of a Candidate Gene." Clin Genet 55, 6 (1999): 466-72.
Dror, Y. and M. H. Freedman. "Shwachman-Diamond Syndrome: An Inherited Preleukemic Bone Marrow Failure Disorder with Aberrant Hematopoietic Progenitors and Faulty Marrow Microenvironment." Blood 94, 9 (1999): 3048-54.
Klupp, N. et al. "Emergence of an Unusual Bone Marrow Precursor B-cell Population in Fatal Shwachman Diamond Syndrome." Arch Pathol Lab Med 124, 9 (2000): 1379-81.
Bouchard, G. et al. "High-resolution Maps of the Murine Chromosome 2 Region Containing the Cholesterol Gallstone Locus, Lith1." Mamm Genome 10, 11 (1999): 1070-4.
Lammert, F. et al. "Phenotypic Characterization of Lith Genes that Determine Susceptibility to Cholesterol Cholelithiasis in Inbred Mice: Integrated Activities of Hepatic Lipid Regulatory Enzymes." J Lipid Res 40, 11 (1999): 2080-90.
Han, T. et al. Apolipoprotein B-100 Gene Xba 1 Polymorphism and Cholesterol Gallstone Disease." Clin Genet 57, 4 (2000): 304-8.
Rubin, M., R. Pakula, and F. M. Konikoff. "Microstructural Analysis of Bile: Relevance to Cholesterol Gallstone Pathogenesis." Histol Histopathol 15, 3 (2000): 761-70.
Hattori, Y. et al. "Role of Phospholipase A2 in Cholesterol Gallstone Formation is Associated with Biliary Phospholipid Species Selection at the Site of Hepatic Excretion: Indirect Evidence." Dig Dis Sci 45, 7 (2000):1413-21.
Hrbasova, M. et al. "Artificial Lipid-protein Complexes Accelerate Cholesterol Crystallisation in Model Bile." Int J Bioehem Cell Bioi 32, 6 (2000): 609-19.
Amigo, L. et al. "Impaired Biliary Cholesterol Secretion and Decreased Gallstone Formation in Apolipoprotein E-deficient Mice Fed a High-cholesterol Diet." Gastroenterology 118, 4 (2000): 772-9.
Xiao, Z. L. et al. "Defect of Receptor-G Protein Coupling in Human Gallbladder with Cholesterol Stones." Am J Physiol Gastrointest Liver Physiol 278, 2 (2000): G251-8.
Wang, D. Q. et al. "Cholic Acid Aids Absorption, Biliary Secretion, and Phase Transitions of Cholesterol in Murine Cholelithogenesis." Am J Physiol 276, 3 Pt 1 (1999): G751-60.
———. "No Pathophysiologic Relationship of Soluble Biliary Proteins to Cholesterol Crystallization in Human Bile." J Lipid Res 40, 3 (1999): 415-25.
Tang, C. et al. "Major Role of Human Liver Microsomal Cytochrome P450 2C9 (CYP2C9) in the Oxidative Metabolism of Celecoxib, a Novel Cyclooxygenase-n Inhibitor." J Pharmacol Exp Ther 293, 2 (2000): 453-9.
Raza, H. et al. "Cloning, Characterisation and Bacterial Expression of Full Length cDNA for the Mouse Liver Microsomal Glutathione S-transferase." Oneol Repm 7, 3 (2000): 645-9.
Muratori, L. et al. "Liverlkidney Microsomal Antibody Type 1 Targets CYP2D6 on Hepatocyte Plasma Membrane [see comments]." Gut 46, 4 (2000): 553-61.
Matsunaga, T. et al. "Characterization of Microsomal Alcohol Oxygenase Catalyzing the Oxidation of 7 Hydroxy-delta 8-tetrahydrocannabinol to 7-oxo-delta 8-tetrahydrocannabinol in Rat Liver." Bioi Pharm Bull 23, 1 (2000): 43-6.
Jolly, C. A., D. C. Wilton, and F. Schroeder. "Microsomal Fatty Acyl-CoA Transacylation and Hydrolysis: Fatty Acyl-CoA Species Dependent Modulation by Liver Fatty acyl-CoA Binding Proteins." Bioehim Biophys Acta 1483, 1 (2000): 185-97.
Teyssier, C. et al. "Metabolism of Diallyl Disulfide by Human Liver Microsomal Cytochromes P-450 and Flavin Containing Monooxygenases." Drug Metab Dispos 27, 7 (1999): 835-41.
Raabe, M. et al. "Analysis of the Role of Microsomal Triglyceride Transfer Protein in the Liver of Tissue-specific Knockout Mice." J Clin Invest 103, 9 (1999): 1287-98.
Oleksiak, M. F. et al. "Identification, Functional Characterization, and Regulation of a New Cytochrome P450 Subfamily, the CYP2Ns." J Bioi Chem 275, 4 (2000): 2312-21.
Okamoto, T., and S. Okabe. "Minimal Effect of Cytokine-independent Hepatitis Induced by Anti-Fas Antibodies on Hepatic Cytochrome P450 Gene Expression in Mice." Int J Mol Med 6, 4 (2000): 459-62.
O'Leary, K. A., and C. B. Kasper. "Molecular Basis for Cell-specific Regulation of the NADPH-Cytochrome P450 Oxidoreductase Gene." Arch Biochem Biophys 379, 1 (2000): 97-108.
Okamoto, T. "Suppression of Cytochrome P450 Gene Expression in the Livers of Mice with Concanavalin A-induced Hepatitis." Eur J Pharmacol 394, 1 (2000): 157-61.
Marc, N. et al. "Regulation of Phenobarbital Induction of the Cytochrome P450 2b9/10 Genes in Primary Mouse Hepatocyte Culture. Involvement of Calcium- and cAMP-dependent Pathways." Eur J Biochem 267, 4 (2000): 963-70.
Larrey, D. "Drug-induced Liver Diseases." J Hepatol 32, 1 (2000): 77-88.
Aithal, P. G., and C. P. Day. "The Natural History of Histologically Proved Drug Induced Liver Disease." Gut 44, 5 (1999): 731-5.
Crouch, M. A., and D. F. Brophy. "Nonsteroidal Antiinflammatory Drug-induced Hepatitis." Ann Pharmaeother 32, 3 (1998): 386.
Okamoto, T., K. Yamamura, and O. Hino. "Expression of the Inducible Form of the Nitric Oxide Synthase Gene in the Livers of Mice with Chronic Hepatitis." Int J Mol Med 6, 3 (2000): 315-7.
Nutt, A. K. et al. "Liver Biopsy in the Evaluation of Patients with Chronic Hepatitis C who have Repeatedly Normal or Near-normal Serum Alanine Aminotransferase Levels [see comments]." Am J Med 109, 1 (2000): 62-4.
Marra, F. et al. "Ligands of Peroxisome Proliferator-activated Receptor Gamma Modulate Profibrogenic and Proinflammatory Actions in Hepatic Stellate Cells." Gastroenterology 119, 2 (2000): 466-78.
Umemura, T. et al. "Analysis of T Cell Repertoire in the Liver of Patients with Chronic Hepatitis C." Clin Exp Immunol 121, 1 (2000): 120-6.
Van, J. et al. "Expression of Vascular Endothelial Growth Factor in Liver Tissues of Hepatitis B." Chung Hua Kan Tsang Ping Tsa Chih 8, 3 (2000): 150-2.
Soguero, C. et al. "Assessment of Genotype and Molecular Evolution of Hepatitis C Virus in Formalin-fixed Paraffin-embedded Liver Tissue from Patients with Chronic Hepatitis C Virus Infection." Lab Invest 80, 6 (2000): 851-6.
Thomas, R. M. et al. "Alphal-antichymotrypsin Globules within Hepatocytes in Patients with Chronic Hepatitis C and Cirrhosis." Hum Pathol 31, 5 (2000): 575-7.
Bertolino, P., G. Klimpel, and S. M. Lemon. "Hepatic Inflammation and Immunity: A Summary of a Conference on the Function of the Immune System within the Liver." Hepatology 31, 6 (2000): 1374-8.
Eckels, D. D. et al. "Immunobiology of Hepatitis C Virus (HCV) Infection: The Role of CD4 T Cells in HCV Infection." Immunol Rev 174 (2000): 90-7.
Rockey, D. C. "Hepatic Fibrogenesis and Hepatitis C." Semi Gastrointest Dis 11, 2 (2000): 69-83.
Wies, I. et al. "Identification of Target Antigen for SLA/LP Autoantibodies in Autoimmune Hepatitis [see comments]." Lancet 355, 9214 (2000): 1510-5.
Takeda, K. et al. "Critical Contribution of Liver Natural Killer T Cells to a Murine Model of Hepatitis." Proc Natl Acad Sci USA 97, 10 (2000): 5498-503.
Pinto, M. A. et al. "Inducible Nitric Oxide Synthase (iNOS) Expression in Liver and Splenic T Lymphocyte Rise are Associated with Liver Histological Damage During Experimental Hepatitis A Virus (HAV) Infection in Callithrixjacchus." Exp Toxicol Patol 52, 1 (2000): 3-10.
Aurisicchio, L. et al. "Liver-specific Alpha 2 Interferon Gene Expression Results in Protection from Induced Hepatitis." J Virol 74, 10 (2000): 4816-23.
Nasir, A., H. S. Arora, and H. E. Kaiser. "Apoptosis and Pathogenesis of Viral Hepatitis C-- An Update." In Vivo 14, 1 (2000): 297-300.
Ohashi, K. et al. "Sustained Survival of Human Hepatocytes in Mice: A Model for in Vivo Infection with Human Hepatitis B and Hepatitis Delta Viruses." Not Med 6, 3 (2000): 327-31.
Ramalho, F. et al. "Correlation of Genotypes and Route of Transmission with Histologic Activity and Disease Stage in Chronic Hepatitis C." Dig Dis Sci 45, 1 (2000): 182-7.
Ishak, K. G. "Pathologic Features of Chronic Hepatitis. A Review and Update." Am J Clin Pathol 113, 1 (2000): 40-55.
Ramakrishna, B. et al. "Familial Intrahepatic Cholestatic Cirrhosis with Positive Antimitochondrial Antibody: Familial Primary Biliary Cirrhosis." J Clin Gastroenterol 30, 3 (2000): 255-8.
Clemente, M. G., and S. De Virgiliis. "Autoantigen Characterization in Liver/Kidney Microsome Positive Hepatitis." Dig Liver Dis 32, 1 (2000): 39-45.
Duclos-Vallee, J. C. et al. "Autoantibodies Associated with Acute Rejection After Liver Transplantation for Type-2 Autoimmune Hepatitis." J Hepatol 33, 1 (2000): 163-6.
Czaja, A. J. et al. "Autoimmune Cholangitis Within the Spectrum of Autoimmune Liver Disease." Repatology 31, 6 (2000): 1231-8.
Czaja, A. J., and P. T. Donaldson. "Genetic Susceptibilities for Immune Expression and Liver Cell Injury in Autoimmune Hepatitis." Immunol Rev 174 (2000): 250-9.
Kanzler, S. et al. "Clinical Significance of Autoantibodies to Soluble Liver Antigen in Autoimmune Hepatitis." J Hepatol 31, 4 (1999): 635-40.
Mangia, A. et al. "Anticardiolipin Antibodies in Patients with Liver Disease." Am J Gastroenterol 94, 10 (1999): 2983-7.
Mackay, I. R., J. M. Davies, and M. J. Rowley. "Towards the Pathogenesis of Autoimmune Liver Disease." J Autoimmun 13, 1 (1999): 163-9.
Ludwig, J. "The Pathology of Primary Biliary Cirrhosis and Autoimmune Cholangitis." Baillieres Best Pract Res Clin Gastroenterol 14, 4 (2000): 601-13.
Gershwin, M. E., et al. "Primary Biliary Cirrhosis: An Orchestrated Immune Response Against Epithelial Cells." Immunol Rev 174 (2000): 210-25.
Lieber, C. S. "Alcohol and the Liver: Metabolism of Alcohol and its Role in Hepatic and Extrahepatic Diseases." Mt Sinai J Med 67, 1 (2000): 84-94.
Kono, H. et al. "Gender Differences in Early Alcohol-induced Liver Injury: Role of CD14, NF-kappaB, and TNF-alpha." Am J Physiol Gastrointest Liver Physiol 278, 4 (2000): 0652-61.
Bautista, A. P. "Impact of Alcohol on the Ability of Kupffer Cells to Produce Chemokines and its Role in Alcoholic Liver Disease." J Gastroenterol Hepatol 15, 4 (2000): 349-56.
Enomoto, N. et al. "Kupffer Cell-derived Prostaglandin E(2) is Involved in Alcohol-induced Fat Accumulation in Rat Liver." Am J Physiol Gastrointest Liver Physiol 279, 1 (2000): 0100-6.
Keshavarzian, A. et al. "Leaky Gut in Alcoholic Cirrhosis: A Possible Mechanism for Alcohol-induced Liver Damage." Am J Gastroenterol 94, 1 (1999): 200-7.
McPhaul, L. W., J. Wang, E. M. Hol. et al. "Molecular Misreading of the Ubiquitin B Gene and Hepatic Mallory Body Formation." Gastroenterology 122 (2002): 1878-1885.
Enomoto, N. et al. "Development of a New, Simple Rat Model of Early Alcohol-induced Liver Injury Based on Sensitization of Kupffer Cells." Hepatology 29, 6 (1999): 1680-9.
Ikejima, K., Y. Takei, and H. Honda. et al. "Leptinreceptor-mediated Signaling Regulates Hepatic Fibrogenesis and Remodeling of Extracellular Matrix in the Rat." Gastroenterology 122 (2002): 1399-1410.
Lin, S. C. et al. "The Influence of Propolis Ethanol Extract on Liver Microsomal Enzymes and Glutathione After Chronic Alcohol Administration." Am J Chin Med 27, 1 (1999): 83-93.
Lin, H. Z., S. Q. Yang, and C. Chuckaree. et al. "Metformin Reverses Fatty Liver Disease in Obese, Leptin-deficient Mice." Nat Med 6 (2000): 998-1003.
Pinzani, M., and P. Gentilini. "Biology of Hepatic Stellate Cells and their Possible Relevance in the Pathogenesis of Portal Hypertension in Cirrhosis." Semin Liver Dis 19, 4 (1999): 397-410.
Vasiliou, V. et al. "Involvement of p65 in the Regulation of NF-kappaB in Rat Hepatic Stellate Cells During Cirrhosis." Biochem Biophys Res Commun 273, 2 (2000): 546-50.
Levy, M. T. et al. "Fibroblast Activation Protein: A Cell Surface Dipeptidyl Peptidase and Gelatinase Expressed by Stellate Cells at the Tissue Remodelling Interface in Human Cirrhosis." Hepatology 29, 6 (1999): 1768-78.
Levine, D. et al. "Expression of the Integrin Alpha8 Betal During Pulmonary and Hepatic Fibrosis." Am J Pathol 156, 6 (2000): 1927-35.
Okazaki, I. et al. "Molecular Mechanism of the Reversibility of Hepatic Fibrosis: with Special Reference to the Role of Matrix Metalloproteinases." J Gastroenterol Hepatol 15, Suppl (2000): D26-32.
Brenner, D. A. et al. "New Aspects of Hepatic Fibrosis." J Hepatol 32, 1 (2000): 32-8.
Friedman, S. L. "Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury." J Bioi Chem 275, 4 (2000): 2247-50.
McCrudden, R., and J. P. Iredale. "Liver Fibrosis, the Hepatic Stellate Cell and Tissue Inhibitors of Metalloproteinases." Histol Histopathol 15, 4 (2000): 1159-68.
Ozaki, I. et al. "Ribozyme-mediated Specific Gene Replacement of the Alpha1-antitrypsin Gene in Human Hepatoma Cells." J Hepatol 31, 1 (1999): 53-60.
Gaillard, M. C., R. Mahadeva, and D. A. Lomas. "Identification of DNA Polymorphisms Associated with the V type Alphal-antitrypsin Gene." Biochim Biophys Acta 1444, 2 (1999): 166-70.
Zhang, G., Y. K. Song, and D. Liu. "Long-term Expression of Human Alphal-antitrypsin Gene in Mouse Liver Achieved by Intravenous Administration of Plasmid DNA Using a Hydrodynamics-based Procedure." Gene Ther 7, 15 (2000): 1344-9.
Volpert, D., J. P. Molleston, and D. H. Perlmutter. "Alphal-antjtrypsin Deficiency-associated Liver Disease Progresses Slowly in Some Children." J Pediatr Gastroenterol Nutr 31, 3 (2000): 258-63.
Parmar, J. S., and D. A. Lomas. "Alpha-1-antitrypsin Deficiency, the Serpinopathies and Conformational Disease." J R Coll Physicians Lond 34, 3 (2000): 295-300.
Lomas, D. A. "Loop-sheet Polymerization: The Mechanism of Alpha1-antitrypsin Deficiency." Respir Med 94, Suppl C:S3-6 (2000).
Rigotti, A., and D. E. Cohen. "The Tangier Disease Gene Encodes Yet Another Pathophysiologically Relevant Atp-binding Cassette Protein." Hepatology 11, 2 (2000): 117-22.
Hayden, M. R. et al. "Cholesterol Efflux Regulatory Protein, Tangier Disease and Familial High-density Lipoprotein Deficiency." Curr Opin Lipidol 11, 2 (2000): 117-22.
Ordovas, J. M. "ABC1: The Gene for Tangier Disease and Beyond." Nutr Rev 58, (3 Pt 1) (2000): 76-9.
Schuler-Luttmann, S. et al. "Cholesterol Efflux from Normal and Tangier Disease Fibroblasts into Normal, High-density Lipoprotein-deficient, and Apolipoprotein E-deficient Plasmas." Metabolism 49, 6 (2000): 770-7.
Gerin, I. et al. "Structure of the Gene Mutated in Glycogen Storage Disease Type lb." Gene 227, 2 (1999): 189-95.
Hou, D. C. et al. "Glycogen Storage Disease Type Ib: Structural and Mutational Analysis of the Microsomal Glucose-6-phosphate Transporter Gene." Am J Med Genet 86, 3 (1999): 253-7.
Galli, L. et al. "Mutations in the Glucose-6-phosphate Transporter (G6PT) Gene in Patients with Glycogen Storage Diseases Type 1b and 1c." FEBS LeU 459, 2 (1999): 255-8.
LiD, B. et al. "Type-1c Glycogen Storage Disease is Not Caused by Mutations in the Glucose-6-phosphate Transporter Gene." Hum Genet 105, 5 (1999): 515-7.
Chiang, S. C. et al. "Glucose-6-phosphatase Gene Mutations in Taiwan Chinese Patients with Glycogen Storage Disease Type Ia." J Hum Genet 45, 4 (2000): 197-9.
Okubo, M. et al. "Heterogeneous Mutations in the Glycogen-debranching Enzyme Gene are Responsible for Glycogen Storage Disease Type ma in Japan." Hum Genet 106, 1 (2000): 108-15.
Li, P., A. B. Bellows, and J. N. Thompson. "Molecular Basis of Iduronate-2-sulphatase Gene Mutations in Patients with Mucopolysaccharidosis Type n (Hunter Syndrome)." J Med Genet 36, 1 (1999): 21-7.
Bunge, S. et al. "Mucopolysaccharidosis Type IIIB (Sanfilippo B): Identification of 18 Novel Alpha-N Acetylglucosaminidase Gene Mutations." J Med Genet 36, 1 (1999): 28-31.
Hartung, S. D. et al. "Enzymatic Correction and Cross-correction of Mucopolysaccharidosis Type I Fibroblasts by Adeno-associated Virus-mediated Transduction of the Alpha-L-iduronidase Gene." Hum Gene Ther 10, 13 (1999): 2163-72.
Kosuga, M. et al. "Adenovirus-mediated Gene Therapy for Mucopolysaccharidosis VII: Involvement of Cross-correction in Wide-spread Distribution of the Gene Products and Long-term Effects of CfLA-4Ig Coexpression." Mol Ther 1, (5 Pt 1) (2000): 406-13.
Sukegawa, K. et al. "Biochemical and Structural Analysis of Missense Mutations in N-acetylgalactosamine-6 Sulfate Sulfatase Causing Mucopolysaccharidosis IV A Phenotypes." Hum Mol Genet 9, 9 (2000): 1283-90.
Bosch, A. et al. "Reversal of Pathology in the Entire Brain of Mucopolysaccharidosis Type in Mice After Lentivirus-mediated Gene Transfer." Hum Gene Ther 11, 8 (2000): 1139-50.
Vervoort, R. et al. "Low Beta-glucuronidase Enzyme Activity and Mutations in the Human Beta-glucuronidase Gene in Mild Mucopolysaccharidosis Type vn, Pseudodeficiency and a Heterozygote." Hum Genet 102, 1 (1998): 69-78.
Beesley, C. E. et al. "Identification of 12 Novel Mutations in the Alpha-N-acetylglucosaminidase Gene in 14 Patients with Sanfilippo Syndiome Type B (Mucopolysaccbaridosis Type IIIB)." J Med Genet 35, 11 (1998): 910-4.
Karsten, S. L. et al. "Identification of 9 Novel IDS Gene Mutations in 19 Unrelated Hunter Syndrome (Mucopolysaccharidosis Type ll) Patients. Mutations in Brief, No. 202. Online." Hum Mutat 12, 6 (1998): 433.
Winchester, B., A. Vellodi, and E. Young. "The Molecular Basis of Lysosomal Storage Diseases and their Treatment." Biochem Soc Trans 28, 2 (2000): 150-4.
Isaac, E. L. et al. "Regulation of the Lysosome-associated Membrane Protein in a Sucrose Model of Lysosomal Storage." Exp Cell Res 254, 2 (2000): 204-9.
Eto, Y., and T. Ohashi. "Gene Therapy/cell Therapy for Lysosomal Storage Disease." J Inherit Metab Dis 23, 3 (2000): 293-8.
Schuchman, E. H. "Hematopoietic Stem Cell Gene Therapy for Niemann-Pick Disease and Other Lysosomal Storage Diseases." ChemPhys Lipids 102, 1-2 (1999): 179-88.
Anderson, R. A., G. M. Bryson, and J. S. Parks. "Lysosomal Acid Lipase Mutations that Determine Phenotype in Wolman and Cholesterol Ester Storage Disease." Mol Genet Metab 68, 3 (1999): 333-45.
vom Dahl, S. et al. "Hepatosplenomegalic Lipidosis: What Unless Gaucher? Adult Cholesteryl Ester Storage Disease (CESD) with Anemia, Mesenteric Lipodystrophy, Increased Plasma Chitotriosidase Activity and a Homozygous Lysosomal Acid Lipase -1 exon 8 Splice Junction Mutation." J Hepato 31, 4 (1999): 741-6.
Ziegler, R. J. et al. "Correction of Enzymatic and Lysosomal Storage Defects in Fabry Mice by Adenovirus Mediated Gene Transfer." Hum Gene Ther 10, 10 (1999): 1667-82.
Sleat, D. E. et al. "Mutational Analysis of the Defective Protease in Classic Late-infantile Neuronal Ceroid Lipofuscinosis, a Neurodegenerative Lysosomal Storage Disorder." Am J Hum Genet 64, 6 (1999): 1511-23.
Havelaar, A. C. et al. "Transport of Organic Anions by the Lysosomal Sialic Acid Transporter: A Functional Approach Towards the Gene for Sialic Acid Storage Disease." FEBS Leu 446, 1 (1999): 65-8.